A Retrospective Study of the Safety and Immunogenicity of MVC-COV1901 Vaccine for People Living with HIV

Background: This study aimed to assess the safety and immunogenicity of MVC-COV1901, a recombinant COVID-19 protein vaccine, containing S-2P protein adjuvanted with CpG 1018 and aluminum hydroxide, for people living with HIV (PWH). Methods: A total of 57 PWH of ≥20 years of age who are on stable ant...

Descripción completa

Detalles Bibliográficos
Autores principales: Cheng, Shu-Hsing, Lien, Chia En, Hsieh, Szu-Min, Cheng, Chien-Yu, Liu, Wang-Da, Lo, Ching-Lung, Ko, Wen-Chien, Chen, Yen-Hsu, Huang, Ching-Tai, Chang, Hsiao-Ting, Hwang, Shinn-Jang, Wang, Ning-Chi, Liu, Ming-Che, Lee, Yu-Lin, Tai, I-Chen, Estrada, Josue Antonio Garcia, Lin, Tzou-Yien, Lee, Wen-Sen
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2022
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9863561/
https://www.ncbi.nlm.nih.gov/pubmed/36679862
http://dx.doi.org/10.3390/vaccines11010018

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9863561/
https://www.ncbi.nlm.nih.gov/pubmed/36679862
http://dx.doi.org/10.3390/vaccines11010018

Ejemplares similares